Plerixafor: AMD 3100, AMD3100, JM 3100, SDZ SID 791

ISSN： 1174-5886

Source： Drugs in R&D, Vol.8, Iss.2, 2007-01, pp. : 113-119

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

AMD 3100 induces rapid mobilisation of CD34+ cells

Inpharma, Vol. 1, Iss. 1432-1433, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Potential Clinical Applications of the CXCR4 Antagonist Bicyclam AMD3100

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 9, 2005-01 ,pp. : 805-824

Bentham Science Publishers

Access to resources Recommend Favorite

MDV3100 for the treatment of prostate cancer

By Mukherji Deborah Pezaro Carmel J De-Bono Johann S

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 2, 2012-02 ,pp. : 227-233

Informa Healthcare

Access to resources Recommend Favorite

Clinical activity and tolerability of enzalutamide (MDV3100) in patients with metastatic, castration-resistant prostate cancer who progress after docetaxel and abiraterone treatment

By Badrising Sushil van der Noort Vincent van Oort Inge M. van den Berg H. Pieter Los Maartje Hamberg Paul Coenen Jules L. van den Eertwegh Alfons J. M. de Jong Igle J. Kerver Emile D. van Tinteren Harm Bergman Andries M.

Cancer, Vol. 120, Iss. 7, 2014-04 ,pp. : 968-975

Blackwell Publishing

Access to resources Recommend Favorite

AMD news from ISPOR

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 555, 2008-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite